Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 6/20 | 0.49 |
| ▸ | ESR2 | Q92731 | 5/20 | 0.49 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | CYP2A6 | P11509 | 2/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.37 |
| ▸ | IDO1 | P14902 | 1/20 | 0.37 |
| ▸ | KIF11 | P52732 | 2/20 | 0.36 |
| ▸ | PYCR1 | P32322 | 1/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.34 |
| ▸ | AGXT | P21549 | 1/20 | 0.33 |
| ▸ | CASP1 | P29466 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | BCHE | P06276 | 1/20 | 0.33 |
| ▸ | ACHE | P22303 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27708349 | 0.91 | ESR1 (0.42) | ESR1ESR2TSHRCYP2A6KIF11 | |
| SCHEMBL9447405 | 0.91 | KIF11 (0.46) | ESR1ESR2KIF11CYP1A2TAAR1 | |
| SCHEMBL28689681 | 0.80 | ACHE (0.46) | ALDH1A1CYP1A2TAAR1HSD17B10BCHE | |
| SCHEMBL9447319 | 0.76 | CASP1 (0.39) | ESR1ESR2TSHRCYP2A6ALDH1A1 | |
| SCHEMBL2439798 | 0.75 | ESR1 (0.43) | ESR1ESR2TSHRCYP2A6ALDH1A1 | |
| SCHEMBL56267 | 0.75 | ATM (0.53) | ESR1ESR2ALDH1A1KIF11CYP1A2 | |
| SCHEMBL11841097 | 0.74 | CASP1 (0.57) | TSHRCYP2A6ALDH1A1KIF11CASP1 | |
| SCHEMBL9447544 | 0.74 | ALDH1A1 (0.48) | ESR1ESR2TSHRALDH1A1KIF11 | |
| SCHEMBL18801247 | 0.72 | ESR1 (0.41) | ESR1ESR2CYP2A6ALDH1A1IDO1 | |
| SCHEMBL11241939 | 0.71 | ESR1 (0.36) | ESR1ESR2CYP2A6ALDH1A1IDO1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8426596-B2 | Process of producing bleach boosters | BASF AKTIENGESELLSCHAFT (DE) | 2013-04-23 | — | — | US | disclosed |
| US-8129531-B2 | Using an isoquinoline compound; alkylation of benzonitrile; reduction ofnitrile to an amine; cyclization | BASF AKTIENGESELLSCHAFT (DE) | 2012-03-06 | — | — | US | disclosed |
| US-20110319622-A1 | PROCESS OF PRODUCING BLEACH BOOSTERS | BASF SE (DE) | 2011-12-29 | — | — | US | disclosed |
| EP-1891192-B1 | ORGANIC CATALYST WITH ENHANCED ENZYME COMPATIBILITY | PROCTER & GAMBLE (US) | 2009-12-16 | — | — | EP | disclosed |
| US-7504371-B2 | Organic catalyst with enhanced enzyme compatibility | THE PROCTER & GAMBLE COMPANY (US) | 2009-03-17 | — | — | US | disclosed |
| US-20080214819-A1 | Process of Producing Bleach Boosters | BASF AKTIENGESELLSCHAFT (DE) | 2008-09-04 | — | — | US | disclosed |
| EP-1896561-A2 | PROCESS OF PRODUCING BLEACH BOOSTERS | BASF SE (DE) | 2008-03-12 | — | — | EP | disclosed |
| EP-1891192-A1 | ORGANIC CATALYST WITH ENHANCED ENZYME COMPATIBILITY | The Procter and Gamble Company (US) | 2008-02-27 | — | — | EP | disclosed |
| US-20070197421-A1 | Organic catalyst with enhanced enzyme compatibility | PROCTER & GAMBLE COMPANY, THE | 2007-08-23 | — | — | US | disclosed |
| WO-2007001261-A1 | ORGANIC CATALYST WITH ENHANCED ENZYME COMPATIBILITY | THE PROCTER & GAMBLE COMPANY (US) | 2007-01-04 | — | — | WO | disclosed |
| WO-2006134144-A2 | PROCESS OF PRODUCING BLEACH BOOSTERS | BASF AKTIENGESELLSCHAFT (DE) | 2006-12-21 | — | — | WO | disclosed |
| US-20060287210-A1 | Organic catalyst with enhanced enzyme compatibility | PROCTER & GAMBLE COMPANY, THE | 2006-12-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080214819-A1 | Process of Producing Bleach Boosters | SQLE, BCHE, CAT | ESR1 2991/4885ESR2 2626/4885TSHR 3477/4885 |
| US-20060287210-A1 | Organic catalyst with enhanced enzyme compatibility | AOX1, ACHE, MPO | ESR1 1112/4885ESR2 2900/4885TSHR 4661/4885 |
| US-20110319622-A1 | PROCESS OF PRODUCING BLEACH BOOSTERS | SQLE, BCHE, CAT | ESR1 2991/4885ESR2 2626/4885TSHR 3477/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.